Christopher John Tovey's most recent trade in Jazz Pharmaceuticals plc was a trade of 4,032 Ordinary Shares done at an average price of $0.0 . Disclosure was reported to the exchange on July 5, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Jazz Pharmaceuticals plc | Christopher John Tovey | EVP, COO & Managing Director E | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.02 per share. | 05 Jul 2022 | 4,032 | 19,872 (0%) | 0% | 0.0 | 81 | Ordinary Shares |
Jazz Pharmaceuticals plc | Christopher John Tovey | EVP, COO & Managing Director E | Sale of securities on an exchange or to another person at price $ 160.00 per share. | 05 Jul 2022 | 4,032 | 15,840 (0%) | 0% | 160 | 645,120 | Ordinary Shares |
Jazz Pharmaceuticals plc | Christopher John Tovey | EVP, COO & Managing Director E | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jul 2022 | 4,032 | 4,031 | - | - | Non-Qualified Stock Option (right to buy) | |
Jazz Pharmaceuticals plc | Christopher John Tovey | EVP, COO & Managing Director E | Sale of securities on an exchange or to another person at price $ 160.00 per share. | 05 Jul 2022 | 1,177 | 14,663 (0%) | 0% | 160 | 188,320 | Ordinary Shares |
Jazz Pharmaceuticals plc | Christopher John Tovey | EVP, COO & Managing Director E | Payment of exercise price or tax liability using portion of securities received from the company at price $ 153.22 per share. | 05 May 2022 | 1,096 | 15,840 (0%) | 0% | 153.2 | 167,929 | Ordinary Shares |
Jazz Pharmaceuticals plc | Christopher John Tovey | EVP & Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 7,820 | 16,936 (0%) | 0% | 0 | Ordinary Shares | |
Jazz Pharmaceuticals plc | Christopher John Tovey | EVP COO & Managing Dir EUR/INT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2021 | 9,091 | 9,116 (0%) | 0% | 0 | Ordinary Shares |